Loading…
This event has ended. View the official site or create your own event → Check it out
This event has ended. Create your own
Learn the latest cancer care information to benefit your patients and earn up to 30 CNE contact hours! Register now at congress.ons.org.
View analytic
Thursday, April 28 • 6:00am - 7:30am
IMBRUVICA® Single-Agent Therapy for Previously Treated Chronic Lymphocyctic Leukemia and Chronic Lymphocytic Leukemia with 17p deletion: A Support and Education Resource for Nursing Professionals*

Sign up or log in to save this to your schedule and see who's attending!

Please join us for a Pharmacyclics LLC, an AbbVie company, and Janssen Biotech, Inc. presentation of IMBRUVICA® (ibrutinib). Karolina Faysman, NP, RN, MSN, ONP, from UCLA Medical Center, will discuss IMBRUVICA®.


Sponsored by Pharmacyclics LLC, an AbbVie company, and Janssen Biotech, Inc